Published in Urology on October 01, 2011
Stem cell therapy for stress urinary incontinence: a critical review. Stem Cells Dev (2012) 1.18
Elastic fibres. J Cell Sci (2002) 3.66
A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: two-year follow-up. Am J Obstet Gynecol (2004) 3.27
Stress urinary incontinence: relative importance of urethral support and urethral closure pressure. J Urol (2008) 2.52
Urinary incontinence in women. Lancet (2006) 2.22
Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology (2004) 2.22
Molecular mechanisms related to parturition-induced stress urinary incontinence. Eur Urol (2008) 2.17
Urinary incontinence prevalence: results from the National Health and Nutrition Examination Survey. J Urol (2007) 1.84
Remodeling of vaginal connective tissue in patients with prolapse. Obstet Gynecol (2005) 1.61
The effect of simulated birth trauma and/or ovariectomy on rodent continence mechanism. Part I: functional and structural change. J Urol (2001) 1.53
Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation (2009) 1.52
Pharmacologically induced thoracic and abdominal aortic aneurysms in mice. Hypertension (2010) 1.37
Increased duration of simulated childbirth injuries results in increased time to recovery. Am J Physiol Regul Integr Comp Physiol (2007) 1.26
Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence. Br J Obstet Gynaecol (1997) 1.22
Long-term effect of ovariectomy and simulated birth trauma on the lower urinary tract of female rats. J Urol (2002) 1.17
Molecular diseases of connective and vascular tissues. II. Amine oxidase inhibition by the lathyrogen, beta-aminopropionitrile. Biochemistry (1967) 1.15
Why do women have stress urinary incontinence? Neurourol Urodyn (2010) 1.14
Striated muscle and nerve fascicle distribution in the female rat urethral sphincter. Anat Rec (Hoboken) (2007) 1.09
Arrangements of collagen fibrils and muscle fibres in the female urethra and their implications for the control of micturition. Br J Urol (1982) 1.04
Lower urogenital tract anatomical and functional phenotype in lysyl oxidase like-1 knockout mice resembles female pelvic floor dysfunction in humans. Am J Physiol Renal Physiol (2008) 1.02
Effects of estrogen, raloxifene and levormeloxifene on alpha1A-adrenergic receptor expression. J Urol (2008) 0.99
Picrosirius-polarization staining method as an efficient histopathological tool for collagenolysis detection in vesical prolapse lesions. Micron (2006) 0.98
The potential of hormones and selective oestrogen receptor modulators in preventing voiding dysfunction in rats. BJU Int (2008) 0.93
Changes in the extracellular matrix in periurethral tissue of women with stress urinary incontinence. Acta Histochem (2006) 0.92
Periurethral connective tissue status of postmenopausal women with genital prolapse with and without stress incontinence. Acta Obstet Gynecol Scand (2003) 0.92
Urethral collagen morphologic characteristics among women with genuine stress incontinence. Am J Obstet Gynecol (2000) 0.87
Alterations of the connective tissue components induced by beta-aminopropionitrile. Exp Mol Pathol (1981) 0.83
Effects of birth trauma and estrogen on urethral elastic fibers and elastin expression. Urology (2010) 0.83
The urethra and its supporting structures in women with stress urinary incontinence: MR imaging using an endovaginal coil. AJR Am J Roentgenol (2003) 0.82
The effect of long-term hormonal treatment on voiding patterns during filling cystometry and on urethral histology in a postpartum, ovariectomized female rat. BJU Int (2010) 0.80
Factors affecting urethrocystographic parameters in urinary continent women. J Clin Ultrasound (1996) 0.78
American Urological Association guideline on the management of priapism. J Urol (2003) 3.77
A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer (2010) 2.84
Defining stem and progenitor cells within adipose tissue. Stem Cells Dev (2008) 2.63
Molecular mechanisms related to parturition-induced stress urinary incontinence. Eur Urol (2008) 2.17
Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med (2010) 1.99
Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol (2002) 1.96
Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol (2010) 1.95
Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn (2011) 1.93
Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med (2010) 1.87
Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am (2005) 1.81
RNAa is conserved in mammalian cells. PLoS One (2010) 1.81
Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation (2006) 1.73
Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy (2010) 1.71
T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J Urol (2009) 1.69
Upregulation of penile brain-derived neurotrophic factor (BDNF) and activation of the JAK/STAT signalling pathway in the major pelvic ganglion of the rat after cavernous nerve transection. Eur Urol (2006) 1.67
Brain activation and sexual arousal in healthy, heterosexual males. Brain (2002) 1.62
Complications of porcine small intestine submucosa graft for Peyronie's disease. J Urol (2007) 1.57
Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy. Int J Urol (2012) 1.56
Chapter 1: The management of erectile dysfunction: an AUA update. J Urol (2005) 1.55
Penile sonographic and clinical characteristics in men with Peyronie's disease. J Sex Med (2009) 1.55
Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction. J Urol (2002) 1.54
The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model. J Sex Med (2010) 1.50
Erection of the human penis and its morphological and vascular basis by Guiseppe Conti. J Sex Med (2008) 1.45
Labeling and tracking of mesenchymal stromal cells with EdU. Cytotherapy (2009) 1.45
Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev (2011) 1.44
Effects of high glucose on human cavernous endothelial cells. Urology (2012) 1.44
Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev (2012) 1.44
Cavernous nerve repair with allogenic adipose matrix and autologous adipose-derived stem cells. Urology (2011) 1.43
Improving erectile function by silencing phosphodiesterase-5. J Urol (2005) 1.43
Activation of bone marrow-derived mesenchymal stromal cells-a new mechanism of defocused low-energy shock wave in regenerative medicine. Cytotherapy (2013) 1.43
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42
The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int (2004) 1.37
Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells. J Sex Med (2008) 1.35
A pathophysiology-based approach to the management of early priapism. Asian J Androl (2012) 1.35
Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med (2010) 1.35
T-shunt with or without tunnelling for prolonged ischaemic priapism. BJU Int (2008) 1.33
Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med (2012) 1.30
Multiple conformations of phosphodiesterase-5: implications for enzyme function and drug development. J Biol Chem (2006) 1.29
AUA guideline on the pharmacologic management of premature ejaculation. J Urol (2004) 1.28
An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat. BJU Int (2007) 1.27
Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease. Eur Urol (2012) 1.27
Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int (2005) 1.24
Peyronie's disease (CME). J Sex Med (2007) 1.24
Up-regulation of estrogen responsive genes in hypospadias: microarray analysis. J Urol (2007) 1.23
Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord. J Neurosci (2008) 1.23
CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. J Biol Chem (2005) 1.21
Expression, distribution and regulation of phosphodiesterase 5. Curr Pharm Des (2006) 1.20
Label retaining and stem cell marker expression in the developing rat urinary bladder. Urology (2011) 1.19
Stem cell therapy for stress urinary incontinence: a critical review. Stem Cells Dev (2012) 1.18
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury. Eur Urol (2011) 1.17
Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat model. J Urol (2010) 1.17